European / MENA approvals
European / MENA approvals and Launch : March saw the first launch of Livazo in the region
European / MENA approvals and Launch : March saw the first launch of Livazo in the region. Algorithm-SAL Launched Livazo on the 23rd March in the Lebanon. The official HCP launch symposium will be in Beirut on the 14th April 2011 at which Prof Farnier will be the key speaker - Press release in March news section.
Publications: The L Ose review Pitavastin: finding its place in therapy was loaded onto the website on the 3rd March and a second Review by Jun Saski “Pitavastatin approved for treatment of Primary hyper cholesterolemia and combined dyslipidemia was loaded onto the website on 10th MarchTwo posters : Pitavastatin has a low risk of drug-drug interactions and Pitavastatin has no detrimental long - term effect on renal function in patients with type 2 diabetes were presented at the DALM conference in Qatar - these can be found under the Publications sections of the website.
Conference Symposium was held at DALM entitled Pitavastatin: A new statin and its role in metabolic syndrome - 150 health care professionals attended - content and details can be found under Meetings; Congress’s 2011. Video footage of the symposium will be uploaded shortly.